Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
JCI Insight|July 24, 2023
Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregationJingyuan Sun, Pei Li, Honglian Gui, et al.Therapeutic Advances in Chronic Disease|June 27, 2022
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scoresYan Huang, Lichang Chen, Rui Huang, et al.Virologica Sinica|January 12, 2021
Laboratory-based Surveillance and Clinical Profile of Sporadic HEV Infection in Shanghai, ChinaJie Lu, Qing Li, Jiayuan Jiang, et al.Journal of Clinical and Translational Hepatology|September 12, 2025
Interim Analysis of 48-week Tenofovir Amibufenamide Treatment in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels: The PROMOTE StudyHonglian Gui, Yingqiu Shen, Lin Tan, et al.Infectious Diseases of Poverty|May 16, 2022
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated statusZhujun Cao, Chenxi Zhang, Shuang Zhao, et al.Expert Opinion on Biological Therapy|September 6, 2018
Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high riskPeipei Ren, Zhujun Cao, Ruidong Mo, et al.The New England Journal of Medicine|December 28, 2022
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19Zhujun Cao, Weiyi Gao, Hong Bao, et al.Pageof 2